Psychedelic Treatment of Movement Disorders With Fewer Side Effects
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for movement disorders, such as tremors and Parkinson's disease, often come with significant side effects and are not entirely effective, while psychedelics have shown potential therapeutic benefits but their use for these conditions remains unexplored.
Innovation Solution
Administering effective doses of psychedelics like LSD, psilocybin, or mescaline to individuals with movement disorders to reduce or eliminate undesired movements, leveraging their serotonin agonist properties and potential neurobiological effects to enhance brain connectivity and neuroplasticity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments (antiparkinson agents, propranolol, primidone) are used to treat movement disorders, then tremors and movement abnormalities are reduced, but significant side effects occur (sedation, drowsiness, fatigue, depression, nausea, vomiting, bradycardia, impotence)
Solution Approach 1:
The patent changes the pharmacological parameter by using psychedelics (serotonin agonists) instead of conventional treatments, fundamentally altering the mechanism of action to achieve tremor reduction without the harmful side effects associated with traditional medications
Solution Approach 2:
The patent introduces psychedelics as an intermediary substance that mediates between the movement disorder and the treatment, acting through serotonin receptor activation to produce therapeutic effects while avoiding direct harmful interactions with the conventional treatment pathways
2Object-affected harmful factors
If current treatments are adjusted or dosing is modified to manage side effects, then some harmful effects are reduced, but the treatment effectiveness is compromised and the underlying neurological issue remains unaddressed
Solution Approach 1:
The patent converts the harmful effect of conventional treatments (side effects) into a benefit by using psychedelics that achieve the same therapeutic goal without these harmful effects, effectively replacing a harmful treatment with a beneficial alternative
3Reliability
If psychedelic substances are administered to treat movement disorders, then tremors and abnormal movements are reduced or eliminated, but the substances induce exceptional subjective effects (dream-like alteration of consciousness, visual imagery, synaesthesia)
Solution Approach 1:
The patent applies local quality by differentiating between the therapeutic effect (tremor reduction) and the subjective effects, focusing the treatment on the neurological benefit while managing the psychological experiences as secondary, controllable phenomena through supervised administration
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Psychedelics effectively reduce tremors and other abnormal movements, offering a novel treatment approach with fewer side effects compared to traditional medications.
Implementation Method 1
Psychedelics are substances capable of inducing exceptional subjective effects such as a dream-like alteration of consciousness, affective changes, enhanced introspective abilities, visual imagery, pseudo-hallucinations, synaesthesia, altered temporal and special perception, mystical-type experiences, disembodiment and ego dissolution (Liechti, 2017; Passie, Halpern, Stichtenoth, Emrich & Hintzen, 2008).
Data Source
AI summary
A method of treating movement disorders, by administering an effective amount of a psychedelic to an individual having a movement disorder, and treating the movement disorder.